Lv41
800 积分 2023-08-16 加入
The current perspective and opportunities of small nucleic acid‐based therapeutics
1个月前
已完结
Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys
1个月前
已完结
Prediction of Interspecies Translation for Targeting Delivery Coefficients of GalNAc-siRNA Silencing Apolipoprotein C-III Using a Mechanistic Minimal Physiologically Based Pharmacokinetic/Pharmacodynamic Model
2个月前
已完结
QR-421a, an antisense oligonucleotide, for the treatment of retinitis pigmentosa due to USH2A exon 13 mutations
2个月前
已关闭
Kallikrein inhibitors for angioedema: the progress of preclinical and early phase studies
2个月前
已完结
Assessment of the Immunogenicity Potential for Oligonucleotide-Based Drugs
2个月前
已完结
Characterization of Nonclinical Drug Metabolism and Pharmacokinetic Properties of Phosphorodiamidate Morpholino Oligonucleotides, A Novel Drug Class for Duchenne Muscular Dystrophy
2个月前
已完结
[Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)]
3个月前
已完结
Impurities in Oligonucleotide Drug Substances and Drug Products
4个月前
已完结
Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of N-Acetylgalactosamine–Conjugated Small Interfering RNA Disposition and Gene Silencing in Preclinical Species and Humans
4个月前
已完结
皖公网安备34019202002308
